Constrained instruments and their application to Mendelian randomization with pleiotropy. Issue 4 (12th January 2019)

• Record Type: Journal Article
• Authors: Jiang, Lai; Oualkacha, Karim; Didelez, Vanessa; Ciampi, Antonio; Rosa‐Neto, Pedro; Benedet, Andrea L.; Mathotaarachchi, Sulantha; Richards, John Brent; Greenwood, Celia M. T.
• Is Part Of: Genetic epidemiology. Volume 43:Issue 4(2019)
• Page Start: 373
• Page End: 401
• Publication Date: 2019-01-12
• Subjects: instrumental variables -- Mendelian randomization -- pleiotropy -- smoothed algorithm; Genetic epidemiology -- Periodicals; Heredity -- Periodicals; Medical geography -- Periodicals; 614
• DOI: 10.1002/gepi.22184
• Languages: English
• ISSNs: 0741-0395

Abstract

Abstract: In Mendelian randomization (MR), inference about causal relationship between a phenotype of interest and a response or disease outcome can be obtained by constructing instrumental variables from genetic variants. However, MR inference requires three assumptions, one of which is that the genetic variants only influence the outcome through phenotype of interest. Pleiotropy, that is, the situation in which some genetic variants affect more than one phenotype, can invalidate these genetic variants for use as instrumental variables; thus a naive analysis will give biased estimates of the causal relation. Here, we present new methods (constrained instrumental variable [CIV] methods) to construct valid instrumental variables and perform adjusted causal effect estimation when pleiotropy exists and when the pleiotropic phenotypes are available. We demonstrate that a smoothed version of CIV performs approximate selection of genetic variants that are valid instruments, and provides unbiased estimates of the causal effects. We provide details on a number of existing methods, together with a comparison of their performance in a large series of simulations. CIV performs robustly across different pleiotropic violations of the MR assumptions. We also analyzed the data from the Alzheimer's disease (AD) neuroimaging initiative (ADNI; Mueller et al., 2005. Alzheimer's Dementia, 11(1), 55–66) to disentangle causal relationships of several biomarkers with AD progression.